文献速递药物不良反应与药物警戒

药物诱导的外周水肿:基于病因的综述

Drug-induced peripheral oedema: An aetiology-based review.
PubMed 文献 · Br J Clin Pharmacol · 2021-02-20

本综述按病理生理机制分类药物诱导的外周水肿,包括毛细血管前小动脉扩张、钠水潴留、淋巴功能不全和毛细血管通透性增加,并举例说明致病药物及管理策略。

要点

  • 药物性外周水肿常被低估和误诊,可导致处方级联。
  • 多数为非炎症性双侧水肿,但部分药物可致红斑或单侧水肿。
  • 明确潜在机制对治疗有效性有重要影响。

核心结论

  • 药物诱导的外周水肿通过四种主要机制发生,识别机制有助于管理。

研究设计与样本

  • 综述,按病理生理机制分析主要致病药物并提供管理示例。

主要发现

  • 水肿严重程度从轻度下肢水肿到全身性水肿不等。
  • 多数水肿为非炎症性双侧,但培美曲塞可致红斑性水肿,西罗莫司可致单侧水肿。
  • 四种机制为毛细血管前小动脉扩张、钠水潴留、淋巴功能不全和毛细血管通透性增加。

临床怎么用

  • 临床应识别药物性外周水肿,避免误诊和处方级联。
  • 根据病理生理机制选择管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many drugs are responsible, through different mechanisms, for peripheral oedema. Severity is highly variable, ranging from slight oedema of the lower limbs to anasarca pictures as in the capillary leak syndrome. Although most often noninflammatory and bilateral, some drugs are associated with peripheral oedema that is readily erythematous (eg, pemetrexed) or unilateral (eg, sirolimus). Thus, drug-induced peripheral oedema is underrecognized and misdiagnosed, frequently leading to a prescribing cascade. Four main mechanisms are involved, namely precapillary arteriolar vasodilation (vasodilatory oedema), sodium/water retention (renal oedema), lymphatic insufficiency (lymphedema) and increased capillary permeability (permeability oedema). The underlying mechanism has significant impact on treatment efficacy. The purpose of this review is to provide a comprehensive analysis of the main causative drugs by illustrating each pathophysiological mechanism and their management through an example of a drug.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Largeau B, Cracowski JL, Lengellé C, et al. Drug-induced peripheral oedema: An aetiology-based review. Br J Clin Pharmacol. 2021. PMID: 33506982. doi:10.1111/bcp.14752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。